iRhythm Zio

A doctor and a patient looking at information on a tablet.
iRhythm Technologies receives another FDA 510(k) for AFib monitoring system
By Emily Olsen | 01:08 pm | July 22, 2022
The latest clearance is for an algorithm that characterizes how much atrial fibrillation a patient is experiencing over time.
iRhythm lauds growing revenue, sales force expansion during Q1 2018 earnings call
By Dave Muoio | 05:21 pm | May 08, 2018
iRhythm Technologies, maker of the Zio XT and Zio AT adhesive heart monitors, announced first quarter financials boasting higher revenue and an improved gross margin during an earnings call for investors earlier this week.